PHOENIX, Arizona—StateServ, a provider of benefit management solutions for durable medical equipment (DME) and pharmaceuticals for the post-acute care market, announced it has rebranded to Dragonfly Health (the company). The new identity marks an inflection point for the company, as it combines DME and pharmacy offerings, enabling a scalable, holistic care-at-home service platform driven by advanced technology and robust analytics. Through its comprehensive offering of equipment and medication solutions, Dragonfly Health seeks to improve quality of life and transform the care-at-home experience for caregivers, patients and their families.
"It's exciting to mark our 20th anniversary with a rebrand to Dragonfly Health, which symbolizes speed, agility, transformation and adaptability as we take stock of our legacy and plan for our future," Paul DiCosmo, co-founder and CEO of Dragonfly Health, said. "We see our new identity as more than a name. It is a guiding force that reflects our commitment to being a trusted, one-stop resource for innovative technology and quality services that simplify and enrich the care-at-home experience for our customers, patients, providers and our employees.
"We combine high tech with a higher calling," DiCosmo continued. "We are investing heavily in technology that will fuel our business so that we can deliver cost-effective products and services with speed and accuracy—anywhere, anytime—allowing us to help our partners and patients enjoy efficient, top-quality care and fortify Dragonfly Health's leading market position."
WindRose Health Investors, LLC, a New York-based health care private equity firm, which acquired StateServ in 2021 and Delta Care RX in 2023, remains a partner in driving Dragonfly Health's mission.
"We believe the Dragonfly Health name will become the standard-bearer for high-quality post-acute care, hospice and care-at-home solutions, and we are proud to support the Company in its evolution," said Alexander Buzik, partner at WindRose.
